After all the bad news that have been going round over the outbreak of the Ebola virus in West African countries, Nigeria, Sierra Leone, Guinea and Liberia, a piece of good news finally arrived some moments ago.

Reporting online in the British journal Nature, researchers at the Public Health Agency of Canada announced that a prototype drug, ZMapp, that has been urgently given to a handful of patients with Ebola has cleared an important test hurdle.

According to the scientists report, the drug test results showed that ZMapp cured lab monkeys that have been infected with the Ebola virus disease.

It was gathered that it is a norm to experiment drugs on animals first and then on progressively larger groups of humans to ensure they are safe and effective.